Results 241 to 250 of about 478,311 (305)
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli +4 more
wiley +1 more source
A Comprehensive Review of Epigenetic Regulation of Vascular Smooth Muscle Cells During Development and Disease. [PDF]
Natali L +5 more
europepmc +1 more source
Ultrasonic diagnosis of congenital descending aortapulmonary vein fistula: a case description. [PDF]
Yue Z +5 more
europepmc +1 more source
Relationship of Pulmonary Artery to Aorta Ratio With Pulmonary Vascular Resistance, Compliance, and Outcomes in COPD and Interstitial Lung Disease in PVDOMICS. [PDF]
Jankowich MD +7 more
europepmc +1 more source
Pathogenesis, histopathology, and mechanisms of pulmonary pathology secondary to chronic left heart failure in animals. [PDF]
Reddy AC +3 more
europepmc +1 more source
Vascular etiologies of unilateral pulmonary fibrosis: Case series and literature overview. [PDF]
Cozzi D +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Pulmonary Medicine, 2001
This review article discusses three topics related to pulmonary vascular disease: 1) pulmonary vascular changes associated with portal hypertension, 2) ANCA-associated pulmonary vasculitis, and 3) Takayasu's arteritis. Hepatopulmonary syndrome and pulmonary hypertension have recently been reported as pulmonary vascular changes accompanied with portal ...
G F, Pineo, R D, Hull
openaire +7 more sources
This review article discusses three topics related to pulmonary vascular disease: 1) pulmonary vascular changes associated with portal hypertension, 2) ANCA-associated pulmonary vasculitis, and 3) Takayasu's arteritis. Hepatopulmonary syndrome and pulmonary hypertension have recently been reported as pulmonary vascular changes accompanied with portal ...
G F, Pineo, R D, Hull
openaire +7 more sources
Comprehensive Physiology, 2011
AbstractDiseases of the pulmonary vasculature are a cause of increased pulmonary vascular resistance (PVR) in pulmonary embolism, chronic thromboembolic pulmonary hypertension (CTEPH), and pulmonary arterial hypertension or decreased PVR in pulmonary arteriovenous malformations on hereditary hemorrhagic telangiectasia, portal hypertension, or ...
Melot, Christian, Naeije, Robert
openaire +2 more sources
AbstractDiseases of the pulmonary vasculature are a cause of increased pulmonary vascular resistance (PVR) in pulmonary embolism, chronic thromboembolic pulmonary hypertension (CTEPH), and pulmonary arterial hypertension or decreased PVR in pulmonary arteriovenous malformations on hereditary hemorrhagic telangiectasia, portal hypertension, or ...
Melot, Christian, Naeije, Robert
openaire +2 more sources

